ORIGINAL RESEARCH
Accepted on 04 Jul 2025
Ambroxol confers neuroprotection against scopolamine-induced Alzheimer's-like pathology by modulating oxidative stress, neuroinflammation, and cognitive deficits via Nrf-2/JNK/GSK-3β signaling pathways
doi 10.3389/fnagi.2025.1607289
- 168 views
